세계의 연속 혈당 모니터링 디바이스 시장 보고서(2025년)
Continuous Glucose Monitoring Devices Global Market Report 2025
상품코드 : 1716935
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

연속 혈당 모니터링 디바이스 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 16.96%로 184억 5,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 의료비 지출 증가, 당뇨병 관리에 대한 인식 증가, 당뇨병 환자 수 증가, 연속 혈당 모니터링 장비의 인기 증가 등의 요인으로 인해 발생할 것으로 예측됩니다. 예측 기간 중 주요 동향으로는 기술 발전, CGM 시스템 혁신, 인수합병, 규제 당국의 승인, 제휴 및 협력 등을 들 수 있습니다.

당뇨병 유병률 증가는 연속 혈당 모니터링 장비 시장의 확대를 촉진할 것으로 예측됩니다. 당뇨병은 인슐린 분비 부족 또는 인슐린 저항성으로 인해 신체가 혈당을 적절히 조절하지 못하는 질환입니다. 당뇨병 증가의 주요 원인은 식습관 장애, 좌식 생활습관, 비만, 고령화, 유전적 소인 등입니다. 연속 혈당 모니터링(CGM) 장비는 혈당 수치에 대한 실시간 데이터를 제공함으로써 당뇨병 관리를 돕고, 적시에 치료 조정 및 생활습관 변화를 가능하게 합니다. 예를 들어 2024년 3월 영국 정부 부서인 Office for Health Improvement &Disparities는 2022년 3월과 2023년 3월 사이에 권장되는 8가지 치료 과정을 모두 받은 1형 당뇨병 환자의 비율이 22% 증가했고, 2형 당뇨병은 21% 증가했다고 보고했습니다. 21% 증가했다고 보고했습니다. 또한 HbA1c 목표치를 달성한 환자의 비율은 37.9%로 전국 당뇨병 감사(NDA)에서 역대 최고치를 기록했습니다. 그 결과, 당뇨병 유병률 증가는 연속 혈당 모니터링 장비 시장의 성장에 크게 기여하고 있습니다.

연속 혈당 모니터링 장비 시장의 주요 업체들은 개인의 혈당 관리 접근성, 정확성, 사용성을 향상시키기 위해 시판되는 지속적 혈당 모니터와 같은 혁신적인 기술 개발에 주력하고 있습니다. 시판 중인 CGM 장비는 사용자가 처방전 없이도 지속적으로 혈당 수치를 모니터링할 수 있게 해줍니다. 예를 들어 2024년 9월 미국 의료기기 회사인 Abbott Laboratories는 Lingo 연속 혈당 모니터링 시스템을 출시했습니다. 이 장비는 사용자에게 실시간 포도당 데이터를 제공하여 하루 종일 혈당를 지속적으로 모니터링하고 즉각적인 피드백을 제공합니다. 보기 쉬운 디스플레이를 갖춘 세련된 디자인이 특징이며, 모바일 앱과 통합하여 추세를 추적하고 경고를 받을 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Continuous glucose monitoring (CGM) devices are used to track blood sugar levels in real time by placing a sensor under the skin. These devices offer continuous data, trend insights, and alerts for both high and low blood sugar levels, which helps manage diabetes more effectively. CGM devices reduce the need for frequent finger pricks and improve glucose control.

The primary components of continuous glucose monitoring devices include transmitters, sensors, and receivers. Transmitters are the components that transmit glucose level data from the sensor to the receiver or connected device for monitoring. They typically connect via Bluetooth or 4G technology. CGM devices are used across various demographics, including both children and adults, for managing conditions such as gestational diabetes, type-1 diabetes, and type-2 diabetes. These devices are utilized in a range of settings, including hospitals, homecare environments, and other healthcare settings.

The continuous glucose monitoring devices market research report is one of a series of new reports from The Business Research Company that provides continuous glucose monitoring devices market statistics, including the continuous glucose monitoring devices industry global market size, regional shares, competitors with the continuous glucose monitoring devices market share, detailed continuous glucose monitoring devices market segments, market trends, and opportunities, and any further data you may need to thrive in the continuous glucose monitoring devices industry. This continuous glucose monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous glucose monitoring devices market size has grown rapidly in recent years. It will grow from $8.41 billion in 2024 to $9.86 billion in 2025 at a compound annual growth rate (CAGR) of 17.22%. The growth during the historic period can be attributed to factors such as enhanced patient safety and improved health outcomes, a growing demand for diabetes management devices, greater usage of CGM devices, an increase in diabetes cases, and rising patient trust in these devices.

The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.45 billion in 2029 at a compound annual growth rate (CAGR) of 16.96%. The anticipated growth in the forecast period is driven by factors such as increased healthcare spending, heightened awareness about diabetes management, a rise in the number of diabetes cases, and the growing popularity of continuous glucose monitoring devices. Key trends in the forecast period include advancements in technology, innovations in CGM systems, mergers and acquisitions, regulatory approvals, and partnerships and collaborations.

The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitoring devices market. Diabetes is a condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The increasing rates of diabetes are primarily attributed to factors such as poor diets, sedentary lifestyles, obesity, aging populations, and genetic predispositions. Continuous glucose monitoring (CGM) devices aid in managing diabetes by providing real-time data on blood glucose levels, enabling timely treatment adjustments and lifestyle changes. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%, while for type 2 diabetes, it increased by 21%. Additionally, the percentage of patients achieving target HbA1c levels reached 37.9%, the highest ever recorded in the National Diabetes Audit (NDA). As a result, the rising prevalence of diabetes is significantly contributing to the growth of the continuous glucose monitoring devices market.

Leading companies in the continuous glucose monitoring devices market are focused on developing innovative technologies, such as over-the-counter continuous glucose monitors, to improve accessibility, accuracy, and usability for individuals managing blood glucose levels. An over-the-counter CGM device allows users to continuously monitor their blood glucose levels without the need for a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched the Lingo continuous glucose monitoring system. This device provides users with real-time glucose data, offering continuous monitoring and instant feedback on blood sugar levels throughout the day. It features a sleek design with easy-to-read displays and integrates with mobile apps for tracking trends and receiving alerts.

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition allows Abbott to enhance its diabetes care offerings by combining Bigfoot Biomedical's smart insulin management systems with its Freestyle Libre technology. Bigfoot Biomedical, a US-based medical technology company, specializes in solutions that integrate with continuous glucose monitoring (CGM) devices.

Major players in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.

North America was the largest region in the continuous glucose monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous glucose monitoring devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous glucose monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous glucose monitoring (CGM) devices include revenues earned by entities by providing services such as real-time glucose monitoring, data sharing, trend analysis, and high or low alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring (CGM) devices market also consists of sales of products including dexcom, freestyle libre, medtronic, and eversense. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Glucose Monitoring Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous glucose monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for continuous glucose monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous glucose monitoring devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Continuous Glucose Monitoring Devices Market Characteristics

3. Continuous Glucose Monitoring Devices Market Trends And Strategies

4. Continuous Glucose Monitoring Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Continuous Glucose Monitoring Devices Growth Analysis And Strategic Analysis Framework

6. Continuous Glucose Monitoring Devices Market Segmentation

7. Continuous Glucose Monitoring Devices Market Regional And Country Analysis

8. Asia-Pacific Continuous Glucose Monitoring Devices Market

9. China Continuous Glucose Monitoring Devices Market

10. India Continuous Glucose Monitoring Devices Market

11. Japan Continuous Glucose Monitoring Devices Market

12. Australia Continuous Glucose Monitoring Devices Market

13. Indonesia Continuous Glucose Monitoring Devices Market

14. South Korea Continuous Glucose Monitoring Devices Market

15. Western Europe Continuous Glucose Monitoring Devices Market

16. UK Continuous Glucose Monitoring Devices Market

17. Germany Continuous Glucose Monitoring Devices Market

18. France Continuous Glucose Monitoring Devices Market

19. Italy Continuous Glucose Monitoring Devices Market

20. Spain Continuous Glucose Monitoring Devices Market

21. Eastern Europe Continuous Glucose Monitoring Devices Market

22. Russia Continuous Glucose Monitoring Devices Market

23. North America Continuous Glucose Monitoring Devices Market

24. USA Continuous Glucose Monitoring Devices Market

25. Canada Continuous Glucose Monitoring Devices Market

26. South America Continuous Glucose Monitoring Devices Market

27. Brazil Continuous Glucose Monitoring Devices Market

28. Middle East Continuous Glucose Monitoring Devices Market

29. Africa Continuous Glucose Monitoring Devices Market

30. Continuous Glucose Monitoring Devices Market Competitive Landscape And Company Profiles

31. Continuous Glucose Monitoring Devices Market Other Major And Innovative Companies

32. Global Continuous Glucose Monitoring Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Glucose Monitoring Devices Market

34. Recent Developments In The Continuous Glucose Monitoring Devices Market

35. Continuous Glucose Monitoring Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기